Australia’s active vaccine safety system

AusVaxSafety commenced routine safety monitoring of 2022 seasonal influenza vaccines used in Australia across all ages in April 2022. The vaccines currently in use are Vaxigrip Tetra®, Fluarix Tetra®, Afluria® Quad (5 years and older), FluQuadri®, Flucelvax® Quad (2 years and older), Influvac® Tetra, Fluad® Quad (65 years and over) and Fluzone® High-Dose Quadrivalent (60 years and over).

Surveillance data are provided by AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following influenza vaccination.

Influenza vaccine safety data for 2023 will be published once influenza vaccines become available and the surveillance program commences. 


Latest influenza vaccine safety data

Click on the tiles below to view 2022 AusVaxSafety influenza vaccine safety data for specific age and population groups. There are currently insufficient data to conduct meaningful analysis for the participants aged <5 years, Aboriginal and Torres Strait Islander participants and pregnant participants groups.